Biocept reported $5.37M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Becton, Dickinson and BDX:US $ 1.33B 95M
Biocept BIOC:US $ 5.37M 177.24K
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Cerulean Pharma CERU:US $ 2.24M 413.69K
Cytori Therapeutics CYTX:US $ 1.99M 521K
General Electric GE:US $ 2.64B 80M
Illumina ILMN:US $ 813M 400M
Quest Diagnostics DGX:US $ 421M 1000K
Thermo Fisher Scientific TMO:US $ 1.73B 214M